about
Habituation of reinforcer effectivenessPsychophysiological assessment of emotional processing in patients with borderline personality disorder with and without comorbid substance use.Effects of smoking abstinence on impulsive behavior among smokers high and low in ADHD-like symptoms.The effects of nicotine on the attentional modification of the acoustic startle response in nonsmokers.Motivated attention: incentive effects on attentional modification of prepulse inhibition.Reinforcement and Stimulant Medication Ameliorate Deficient Response Inhibition in Children with Attention-Deficit/Hyperactivity Disorder.The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race.Early adolescent alcohol use in context: how neighborhoods, parents, and peers impact youth.The impact of pre-cessation varenicline on behavioral economic indices of smoking reinforcement.Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokersSelf-regulation in ADHD: the role of error processingInternalizing and externalizing problem behavior and early adolescent substance use: a test of a latent variable interaction and conditional indirect effects.Growth trajectories of alcohol information processing and associations with escalation of drinking in early adolescence.Reinforcement enhances vigilance among children with ADHD: comparisons to typically developing children and to the effects of methylphenidate.Revised Reinforcement Sensitivity Theory and Laboratory Assessment of BIS and BAS in ChildrenEvaluating cognitive and motivational accounts of greater reinforcement effects among children with attention-deficit/hyperactivity disorder.Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline SmokingUse of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trialImpact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.Improving working memory in children with attention-deficit/hyperactivity disorder: the separate and combined effects of incentives and stimulant medication.Does Extended Pre Quit Bupropion Aid in Extinguishing Smoking Behavior?Reaction time variability in ADHD: a reviewTest-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking SmokersThe moderating role of cognitive capacities in the association between social norms and drinking behaviorsTrajectories of Reinforcement Sensitivity During Adolescence and Risk for Substance UseThe interaction between self-regulation and motivation prospectively predicting problem behavior in adolescence.The effects of incentives on visual-spatial working memory in children with attention-deficit/hyperactivity disorder.The effects of acute abstinence from smoking and performance-based rewards on performance monitoring.The effects of performance-based rewards on neurophysiological correlates of stimulus, error, and feedback processing in children with ADHD.Premature responding is associated with approach to a food cue in male and female heterogeneous stock ratsSleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment?Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial.Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline.Risky behaviors, e-cigarette use and susceptibility of use among college students.Efficacy of a family-focused intervention for young drivers with attention-deficit hyperactivity disorder.Impulsivity and risk-taking in borderline personality disorder with and without substance use disorders.Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking.Measures and predictors of varenicline adherence in the treatment of nicotine dependence.The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder.
P50
Q26864421-E1BD7026-14C5-4E1A-8ECE-F3383113DEB1Q30435229-55425D2C-0D3F-4927-9465-AA18758D09EDQ30459647-581387C5-C0D4-4A9B-9B1E-050FA9C26467Q30490869-244FCD7A-871F-454E-8E73-00784A99E3D6Q30490871-E8321BCD-BCAE-4B9E-A1A7-8EDF3982CF63Q30680214-E2E2F5A7-B1A1-4E7C-A0B9-C6702794AAB9Q33693188-89837EB6-31C9-45B9-B082-501DEE55E19CQ33813552-4E34D173-F172-45B2-AC17-996A55F0D0C5Q33943158-B05C5C5A-EE0D-4B82-9150-824D9666CA7EQ34135377-06818AD6-8D1A-4515-8C00-276452D0DD5AQ34188507-631B3752-D664-4FE0-BE2D-C016ED3CAF83Q34195678-8368D33A-19C1-43F6-BBEE-1186B16C445CQ34195830-03014D44-A7F0-4782-92B0-438D50E947C5Q34725704-9AEA5B9F-000B-4513-8BE0-F825237EC12EQ34991030-E0E6FDC3-FB2D-4EAC-A9EC-9865101A49ADQ35627223-6F61D077-2DEE-486F-B173-7E5DD4EA168DQ35641707-7B1D5654-2D40-4F84-948B-FCBDFAB4EDBBQ35782141-4DD08FBE-8EDB-4566-9C27-DACA0CBF9215Q35885499-FA781DBC-38E2-40BB-B135-3819D57111D1Q36164907-F98259BA-DEF3-4E17-9099-8D708C1B124EQ36174459-DC105F68-6CC6-4DCE-A11C-BE351056C5F0Q36181354-AF4B40FE-7CAB-4BB7-A515-EDCD6F308E6BQ36233143-4CAE17B6-9E58-469F-980B-1CF137E9D184Q36303865-F2BED863-3B48-49AA-A75C-92A5B4D54D07Q36467557-831DCE83-3111-41B5-835A-5DE4D2CF6241Q36922595-4F783101-C1A6-4D74-BC67-3B23DB607E34Q37053835-A324F90A-6432-46CB-A5F3-D31434C4B8B0Q37114438-97151937-2865-460A-8947-706DD80CD1F2Q37201020-F1D976BB-2D7A-4CF9-AB94-40E182F02BD0Q37253902-8962C45A-A5AF-4D8F-AF9A-9292F95C4090Q37261097-5296308A-2366-4EC2-927C-FF291A96E2A5Q38758931-0F281F67-6452-4B60-813F-4108672A77C4Q38866239-5EFF66BE-BAB2-4FAC-9E9B-DCA6040868BCQ39013297-77717855-370B-488D-BE32-F4EDDA596339Q39041535-B25D4074-D4C7-47CF-B277-FF2B7AFA4600Q39400638-0322F75C-6CE4-4FF2-AF33-2EFDCE6603F6Q39636613-3C6DAE29-3B2F-418F-B7CC-E60CE866FC3EQ39765572-6CF4BC94-FD07-424A-B13F-96830B55F751Q40114814-F85B0138-9870-4506-BB74-9E0B700FEFD4Q44206074-7D407CAF-AC88-41D3-B111-28BAB8D54FCF
P50
description
researcher
@en
wetenschapper
@nl
name
L W Hawk
@en
L W Hawk
@nl
type
label
L W Hawk
@en
L W Hawk
@nl
prefLabel
L W Hawk
@en
L W Hawk
@nl
P106
P31
P496
0000-0001-6593-9746